Autor: |
Abbara S, Guillemot D, Smith DRM, El Oualydy S, Kos M, Poret C, Breant S, Brun-Buisson C, Watier L |
Jazyk: |
angličtina |
Zdroj: |
Emerging infectious diseases [Emerg Infect Dis] 2024 May; Vol. 30 (5), pp. 974-983. |
DOI: |
10.3201/eid3005.231555 |
Abstrakt: |
We investigated links between antimicrobial resistance in community-onset bacteremia and 1-year bacteremia recurrence by using the clinical data warehouse of Europe's largest university hospital group in France. We included adult patients hospitalized with an incident community-onset Staphylococcus aureus, Escherichia coli, or Klebsiella spp. bacteremia during 2017-2019. We assessed risk factors of 1-year recurrence using Fine-Gray regression models. Of the 3,617 patients included, 291 (8.0%) had >1 recurrence episode. Third-generation cephalosporin (3GC)-resistance was significantly associated with increased recurrence risk after incident Klebsiella spp. (hazard ratio 3.91 [95% CI 2.32-6.59]) or E. coli (hazard ratio 2.35 [95% CI 1.50-3.68]) bacteremia. Methicillin resistance in S. aureus bacteremia had no effect on recurrence risk. Although several underlying conditions and infection sources increased recurrence risk, 3GC-resistant Klebsiella spp. was associated with the greatest increase. These results demonstrate a new facet to illness induced by 3GC-resistant Klebsiella spp. and E. coli in the community setting. |
Databáze: |
MEDLINE |
Externí odkaz: |
|